PADPRO MODEL #2516

K020203 · Padpro, LLC · MKJ · May 8, 2002 · Cardiovascular

Device Facts

• Record ID: K020203
• Device Name: PADPRO MODEL #2516
• Applicant: Padpro, LLC
• Product Code: MKJ · Cardiovascular
• Decision Date: May 8, 2002
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 870.5310
• Device Class: Class 3
• Attributes: Therapeutic

Intended Use

The PadPro non-radiotransparent (radiotranslucent with minor shadowing) external electrodes are indicated for use in external pacing, defibrillation and monitoring applications as a non-sterile, disposable device for single patent use only. The electrodes provide the conductive interface between the defibrillator and/or the external transcutaneous (noninvasive) cardiac pacemaker and the patient's skin. The electrode is intended for use on adult patients. When a patient requires defibrillation, cardioversion or external pacing, these electrodes will be applied to the patient and connected to the instrument. This device is intended for use on defibrillators whose output is classified as low power (360 joule maximum).

Device Story

PadPro 2516 Multifunction Electrodes are disposable, radiotranslucent, self-adhesive pads; provide conductive interface between patient skin and external defibrillators/pacemakers. Used in hospitals and paramedic settings; applied by clinicians. Features high-tack polymer adhesive gel for uniform current distribution; adapter system allows compatibility with various OEM defibrillator/pacing units. Enables continuous monitoring and therapy (defibrillation/pacing/cardioversion) without replacing pads during patient transport. Benefits include standardized connectivity across different device brands and improved clinical workflow efficiency.

Clinical Evidence

Bench testing only. Device performance verified against IEC 601-1 (1988) and ANSI/AAMI DF-39 standards for safety and effectiveness.

Technological Characteristics

Radiotranslucent, non-sterile, latex-free, self-adhesive electrodes. Polymer adhesive gel for current distribution. Compatible with low-power defibrillators (max 360J). Meets IEC 601-1 and ANSI/AAMI DF-39 standards. No software or electronic components.

Indications for Use

Indicated for adult patients requiring external pacing, defibrillation, cardioversion, or ECG monitoring. Used as a conductive interface between the patient's skin and external defibrillators or transcutaneous cardiac pacemakers (max 360 joules).

Regulatory Classification

Identification

An automated external defibrillator (AED) system consists of an AED and those accessories necessary for the AED to detect and interpret an electrocardiogram and deliver an electrical shock (e.g., battery, pad electrode, adapter, and hardware key for pediatric use). An AED system analyzes the patient's electrocardiogram, interprets the cardiac rhythm, and automatically delivers an electrical shock (fully automated AED), or advises the user to deliver the shock (semi-automated or shock advisory AED) to treat ventricular fibrillation or pulseless ventricular tachycardia.

Predicate Devices

• Katecho KDP-60 K-Defib/Pace Adult Electrode (K981737)

Submission Summary (Full Text)

{0}------------------------------------------------

# MAY 0 8 2002

#### EXHIBIT 2

PadPro LLC. 5643 Plymouth Rd. Ann Arbor, Mi 48105 Phone: [phone] Fax: [phone] Contact: Cliff Poppy, President December 12, 2000 510(k) Summary of Safety and Effectiveness

- 1. Identification of the Device: Proprietary-Trade Name: "PadPro" 2516 Multifunction Electrodes Classification Name: Electrode, Electrocardiograph, Multi-Function; MLN Common/Usual Name: Defibrillator Electrode
- 2. Equivalent legally marketed device: This identical in function to the Katecho KDP-60 K-Defib/Pace Adult Electrode (K981737) and nearly identical in design.
- 3. Indications for Use: The PadPro Radiotranslucent (minor shadowing) external electrodes are indicated for use in external pacing, defibrillation and monitoring applications as a non-sterile, disposable device for single patent use only. The electrodes provide the conductive interface between the defibrillator and/or the external transcutaneous (noninvasive) cardiac pacemaker and the patient's skin. The electrode is intended for use on adult patients. When a patient requires defibrillation, cardioversion or external pacing, these electrodes will be applied to the patient and connected to the instrument. This device is intended for use on defibrillators whose output is classified as low power (360 joule maximum).
- 4. Description of the Devices: Features & Benefits:

The electrodes are multifunction because they can be used for defibrillation, pacing, cardioversion, and monitoring. PadPro electrodes can be used on all makes and models of defibrillator, including all of the Bi-Phasic units. Radio transparent. "One Pad System" enables the pads to stay with the patient as they move through departments. PadPro has an electrode for any clinical need or patient situation. The high tack adhesive gel allows PadPro electrodes to be repositioned multiple times. PadPro can provide onsite conversion of current cables to accept the PadPro electrodes. The polymer adhesive gel allows superior contact for uniform current distribution and more effective defibrillation and pacing. PadPro's adapter system simply plugs into the OEM cable. Standardization of products - One connector can be used throughout the institution, no matter what brand or model of defibrillation/pacing unit is being used. All PadPro products are Latex free.

{1}------------------------------------------------

| Comparison Areas | Katecho KDP-60 K-Defib/Pace<br>Adult Electrode (K981737) | "PadPro" Defibrillator<br>Electrodes |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------|
| Indications for use | For use as disposable electrodes for<br>automatic and manual external<br>defibrillators for monitoring, pacing,<br>cardioversion, and defibrillation | SAME |
| Where used | Hospitals and Paramedic situations | SAME |
| Basic features | Radiotranslucent, non sterile, latex<br>free, single patient use, self adhesive,<br>in sealed foil pouch. | Radiotranslucent "minor<br>shadowing" non sterile,<br>latex free, single patient use,<br>self adhesive, in sealed foil<br>pouch. |
| Standard met | International Electrotechnical<br>Commission (IEC) 601-1: Medical<br>Electrical Equipment 601-1 (1988) Part<br>1: General requirements for safety<br>Amendment No. 1 (1991) Amendment<br>No. 2 (1995 and Sec.898.12<br>Performance standard;<br>ANSI/AAMI DF-39 (3.3.19)<br>standard, self adhesive electrodes for<br>monitoring and defibrillation | SAME |

- Safety and Effectiveness, comparison to predicate device: 5.
1

:

- Conclusion In all respects, the PadPro System Defibrillator Electrodes are substantially 6. equivalent to other electrodes that are legally marketed for this purpose. The device meets the standards referenced above.

{2}------------------------------------------------

# DEPARTMENT OF HEALTH & HUMAN SERVICES

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

**MAY 08 2002**

PadPro LLC c/o Mr. Daniel Kamm, P.E. Regulatory Engineer Kamm & Associates P.O. Box 7007 Deerfield, IL 60015

Re: K020203

Trade Name: "PadPro" 2516 Multifunction Electrodes Regulation Number: 21 CFR 870.2360 Regulation Name: Electrode, Electrocardiograph, Multifunction Regulatory Class: Class II (two) Product Code: MLN Dated: February 25, 2002 Received: February 26, 2002

Dear Mr. Kamm:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

## Page 2 - Mr. Daniel Kamm

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Dat Tuh
Dr. Dan Till, Ph.D.

onna-Bea Tillman, Ph.D. Acting Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

### j) Indications for Use

510(k) Number_

Device Name: "PadPro" 2516 Multifunction Electrodes

#### Indications for Use:

The PadPro non-radiotransparent (radiotranslucent with minor shadowing) external electrodes are indicated for use in external pacing, defibrillation and monitoring applications as a non-sterile, disposable device for single patent use only. The electrodes provide the conductive interface between the defibrillator and/or the external transcutaneous (noninvasive) cardiac pacemaker and the patient's skin. The electrode is intended for use on adult patients.

When a patient requires defibrillation, cardioversion or external pacing, these electrodes will be applied to the patient and connected to the instrument. This device is intended for use on defibrillators whose output is classified as low power (360 joule maximum).

Concurrence of CDRH, Office of Device Evaluation (ODE)

| Prescription Use | <span style="text-decoration: overline;">X</span> | OR | Over the Counter Use | <span style="text-decoration: overline;"></span> |
|------------------|---------------------------------------------------|----|----------------------|--------------------------------------------------|
| | | | (Per 21 CFR 801.109) | |

| Division of Cardiovascular & Respiratory Devices | |
|--------------------------------------------------|--|
| 510(k) Number | |

6